Trinity Bio ADR
(TRIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,900 | -14,764 | -8,798 | -31,789 | -14,833 |
| Depreciation Amortization | 1,955 | 1,295 | 638 | 1,865 | 1,441 |
| Accounts receivable | N/A | N/A | N/A | -2,368 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 8,185 | N/A |
| Other Working Capital | 4,675 | 4,111 | 3,063 | 4,075 | -2,349 |
| Other Operating Activity | 8,816 | 4,766 | 2,212 | 15,841 | 8,199 |
| Operating Cash Flow | $-4,454 | $-4,592 | $-2,885 | $-4,191 | $-7,542 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -99 | -93 | -56 | -405 | -248 |
| Net Acquisitions | N/A | N/A | N/A | -12,904 | -12,903 |
| Purchase Sale Intangibles | -5,320 | -3,855 | -1,926 | -9,659 | -7,080 |
| Other Investing Activity | -5,320 | -3,855 | -1,926 | -9,659 | -7,080 |
| Investing Cash Flow | $-5,419 | $-3,948 | $-1,982 | $-22,968 | $-20,231 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,000 | 6,000 | 4,000 | 30,176 | 28,175 |
| Common Stock Issued | 547 | 547 | 548 | 7,391 | 6,847 |
| Other Financing Activity | -2,560 | -1,683 | -811 | -8,757 | -8,018 |
| Financing Cash Flow | $5,987 | $4,864 | $3,737 | $28,810 | $27,004 |
| Exchange Rate Effect | 60 | 55 | 29 | -175 | -82 |
| Beginning Cash Position | 5,167 | 5,167 | 5,167 | 3,691 | 3,691 |
| End Cash Position | 1,341 | 1,546 | 4,066 | 5,167 | 2,840 |
| Net Cash Flow | $-3,826 | $-3,621 | $-1,101 | $1,476 | $-851 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,454 | -4,592 | -2,885 | -4,191 | -7,542 |
| Capital Expenditure | -99 | -93 | -56 | -405 | -248 |
| Free Cash Flow | -4,553 | -4,685 | -2,941 | -4,596 | -7,790 |